ImmPACT Bio Names Sylvain Roy as Chief Technology Officer
- Tuesday, May 10, 2022, 7:00
- Finance
- Add a comment
— Longtime pharmaceutical industry executive brings over two decades of experience in cell and gene therapy, global technical operations, and leading high-performing teams — CAMARILLO, Calif., May 10, 2022 /PRNewswire/ — ImmPACT Bio USA, Inc. (“ImmPACT Bio”), a clinical-stage company…
About the Author
adminasapcorp has written 41558 stories on this site.